Effects of telemedicine interventions in improving continuous positive airway pressure adherence in patients with obstructive sleep apnoea: a meta-analysis of randomised controlled trials

• Published in: Sleep & breathing 2021-12, Vol.25 (4), p.1761-1771
• Main Authors: Hu, Yuli, Su, Yijia, Hu, Sanlian, Ma, Jun, Zhang, Zuoyan, Fang, Fang, Guan, Jian
• Format: Article
• Language: English
• Subjects: Apnea; Clinical trials; Continuous Positive Airway Pressure; Dentistry; Humans; Internal Medicine; Intervention; Medicine; Medicine & Public Health; Meta-analysis; Neurology; Otorhinolaryngology; Outcome Assessment, Health Care; Patient Compliance; Pediatrics; Pneumology/Respiratory System; Randomized Controlled Trials as Topic; Respiratory tract; Sensitivity analysis; Sleep; Sleep and wakefulness; Sleep apnea; Sleep Apnea, Obstructive - therapy; Sleep Breathing Physiology and Disorders • Review; Sleep disorders; Systematic review; Telemedicine
• ISSN: 1520-9512; 1522-1709
• DOI: 10.1007/s11325-021-02292-5

Purpose This meta-analysis was conducted to assess the effects of telemedicine interventions on continuous positive airway pressure (CPAP) adherence in patients with obstructive sleep apnoea (OSA). Methods The PubMed, Cochrane Library, OVID, Web of Science and EBSCO host databases were searched from January 2004 to February 2020 for randomised controlled trials (RCTs) that assessed the effects of telemedicine interventions on CPAP adherence in patients with OSA. The study inclusion criteria were RCTs that compared patients who received telemedicine interventions with a control group and reported a change in CPAP adherence. The primary outcome was the improvement in CPAP adherence. Results In total, there were 11 RCTs ( n = 1358) with quantitative analyses. Intervention times ranged from 1 to 6 months. Compared to controls, the telemedicine group exhibited better adherence to CPAP therapy (pooled mean difference (MD) = 0.57, 95% CI = 0.33 to 0.80, I 2 = 7%, p < 0.00001). We performed sensitivity analyses by the type of telemedicine intervention, comorbidity burden, and OSA severity to explore whether or not their effect sizes may have affected the time of CPAP application. We performed subgroup analyses by follow-up duration, age, and OSA Epworth sleepiness scale (ESS) symptoms to determine if their effect sizes may have affected the time of CPAP application. However, these analyses did not change the statistical significance of the pooled estimate. Conclusions The use of telemedicine for up to 6 months may enhance CPAP adherence in patients with OSA, when compared to no intervention. Our study was searched from January 2004 to February 2020 for randomised controlled trials (RCTs) that assessed the effects of telemedicine interventions on CPAP adherence in patients with OSA. Future studies can continue to search for articles after February 2020